Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery.
作者信息
Arora Poonam, Nainwal Lalit Mohan, Athari Seyyed Shamsadin
机构信息
SGT College of Pharmacy, SGT University, Gurugram, India.
School of Medical and Allied Sciences, G. D. Goenka University, Gurugram, India.
出版信息
Front Pharmacol. 2024 Jul 9;15:1419138. doi: 10.3389/fphar.2024.1419138. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Molecular pharmacological approaches against lung diseases: targeted drug discovery.社论：针对肺部疾病的分子药理学方法：靶向药物发现
Front Pharmacol. 2024 Jul 9;15:1419138. doi: 10.3389/fphar.2024.1419138. eCollection 2024.
2
[Next Generation Antibody Therapeutics Using Bispecific Antibody Technology].[使用双特异性抗体技术的下一代抗体疗法]
Yakugaku Zasshi. 2017;137(7):831-836. doi: 10.1248/yakushi.16-00252-3.
3
Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology.单克隆抗体、双特异性抗体和抗体药物偶联物在肿瘤血液学中的应用。
Recent Pat Anticancer Drug Discov. 2020;15(4):272-292. doi: 10.2174/1574892815666200925120717.
4
Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.治疗性抗体的开发针对 G 蛋白偶联受体和离子通道：在呼吸疾病中的机会、挑战和治疗潜力。
Pharmacol Ther. 2017 Jan;169:113-123. doi: 10.1016/j.pharmthera.2016.04.013. Epub 2016 May 3.
5
Bispecific antibodies for viral immunotherapy.用于病毒免疫治疗的双特异性抗体。
Hum Vaccin Immunother. 2017 Apr 3;13(4):836-842. doi: 10.1080/21645515.2016.1251536. Epub 2016 Oct 27.
6
Full-length recombinant antibodies from : production, characterization, effector function (Fc) engineering, and clinical evaluation.全长重组抗体：生产、表征、效应功能（Fc）工程和临床评估。
MAbs. 2022 Jan-Dec;14(1):2111748. doi: 10.1080/19420862.2022.2111748.
7
A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.一种VHH单域平台，可用于发现和开发针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体的单特异性抗体和模块化中和双特异性抗体。
Antib Ther. 2024 May 3;7(2):164-176. doi: 10.1093/abt/tbae009. eCollection 2024 Apr.
8
Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.用于双特异性靶向的双可变域免疫球蛋白分子的生成。
Methods Enzymol. 2012;502:25-41. doi: 10.1016/B978-0-12-416039-2.00002-1.
9
Fine-tuning bispecific therapeutics.双特异性治疗药物的优化调整。
Pharmacol Ther. 2020 Aug;212:107582. doi: 10.1016/j.pharmthera.2020.107582. Epub 2020 May 23.
10
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds.使用单特异性和双特异性抗体或其他支架靶向HER3。
MAbs. 2016 Oct;8(7):1195-1209. doi: 10.1080/19420862.2016.1212147. Epub 2016 Aug 17.
本文引用的文献
1
Orally administered solasodine, a steroidal glycoalkaloid, suppresses ovalbumin-induced exaggerated Th2-immune response in rat model of bronchial asthma.口服给予甾体糖苷生物碱茄碱可抑制支气管哮喘大鼠模型中卵清蛋白诱导的过度 Th2 免疫反应。
Chem Biol Interact. 2022 Oct 1;366:110138. doi: 10.1016/j.cbi.2022.110138. Epub 2022 Sep 6.
Zotero 插件